Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The content contained in this article is for informational purposes only
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Firan, M
That year one in eight people were thought to be living with obesity around the world (WHO 2024)
Soluble fibre supplementation with and without a probiotic in adults with asthma: A 7-day randomised, double blind, three way cross-over trial
While their therapeutic benefits are well-established, the relationship between GLP-1RAs and cancer risk has become a critical focus of clinical investigation
US$ 22.17
US$ 25.53
US$ 25.59
